Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analysts Remain Bullish on McKesson with Increased Price Target

Elaine Mendonca by Elaine Mendonca
March 6, 2024
in Breaking News
0
IT-Healthcare
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

UBS analyst Kevin Caliendo has reiterated his positive outlook on McKesson (NYSE:MCK) by maintaining a Buy rating and increasing the price target to $620, up from $575. This adjustment reflects his confidence in the company’s performance moving forward.

_____

Other analysts have also weighed in on McKesson, offering a range of price targets. The average price target sits at $556.92, with the highest forecast at $600.00. Overall, analysts are generally optimistic about McKesson, with a consensus of a Strong Buy rating based on 10 buy ratings and 2 hold ratings.

McKesson Corporation (MCK) Stock Price Dips Slightly on March 6, 2024: Potential for Further Growth Ahead

On March 6, 2024, McKesson Corporation (MCK) experienced a slight decrease in its stock price, closing at $528.08. This represents a 0.41% drop from the previous day’s close. Despite this dip, MCK is still trading near the top of its 52-week range and above its 200-day simple moving average, indicating strong performance over the long term. Investors and analysts will be closely monitoring MCK’s stock performance in the coming days to see if this slight decrease is indicative of a larger trend or simply a temporary fluctuation. With the company trading near the top of its 52-week range, there may be potential for further growth if MCK can maintain its strong position in the market.

McKesson Corporation Stock Performance: Revenue Up, Net Income Mixed, EPS Shows Growth

On March 6, 2024, investors closely monitored the stock performance of McKesson Corporation (MCK) as the company released its latest financial data. According to CNN Money, McKesson reported a total revenue of $276.71 billion for the past year, which represents a 4.83% increase compared to the previous year. In the third quarter of the fiscal year, the company generated $80.90 billion in total revenue, reflecting a 4.77% increase from the previous quarter.

In terms of net income, McKesson reported a net income of $3.56 billion for the past year, marking a significant 219.57% increase compared to the previous year. However, in the third quarter, the company’s net income decreased by 11.3% to $589.00 million.

Earnings per share (EPS) also showed a mixed performance for McKesson. The company reported an EPS of $25.04 for the past year, representing a substantial 246.31% increase compared to the previous year. In the third quarter, the EPS decreased by 10.3% to $4.42.

Tags: MCK
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Healthcare-and-IT

Neptune Wellness Solutions Faces Delisting from Nasdaq Looks to OTCQB Market

Fiances and technology

The Threat of AIGenerated Election Disinformation

NTSB Investigative Hearing Raises Concerns About Boeing 737 Max 9 Safety Practices

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com